Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TREATMENT SATISFACTION COMPARISON IN RHEUMATOID ARTHRITIS PATIENTS BETWEEN TOFACITINIB CITRATE AND ADALIMUMAB, EACH USED IN RHEUMATOID ARTHRITIS TREATMENT

NCT03703817 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03703817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03703817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TREATMENT SATISFACTION COMPARISON IN RHEUMATOID ARTHRITIS PATIENTS BETWEEN TOFACITINIB CITRATE AND ADALIMUMAB, EACH USED IN RHEUMATOID ARTHRITIS TREATMENT
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
July 2, 2018
Completion date
March 12, 2020
Enrollment
421 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis